by American Cancer Society (ACS) Credit: CC0 Public DomainProstate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with the disease this year, with close to 35,000 deaths. Black...
by University College London pet scanCredit: CC0 Public DomainThe REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 participants found to have serious prostate cancer, 15 had a ‘low’ PSA score...
By Paul McClure August 14, 2023 Researchers have uncovered the pathway that leads to an aggressive form of prostate cancer and a potential treatment for it Depositphotos Researchers have uncovered the molecular mechanism that drives an aggressive form of prostate cancer that doesn’t respond well to typical treatments. Importantly, they also identified a drug currently undergoing...
by American Chemical Society Prostate cancer cells. Credit: NIH Image Gallery To explore why prostate cancer disproportionately sickens and kills Black men, researchers are looking to another disorder, diabetes, which alters metabolism. They used this approach in a preliminary clinical trial and today report the identification of four metabolism-related biomarkers linked to an increased risk of metastatic prostate...
AMERICAN CHEMICAL SOCIETY Prostate cancer is a leading cause of death among American men, and it’s resistant to one of the most powerful chemotherapy medications — cisplatin. Now, researchers reporting in ACS Central Science have developed the first therapy of its kind that disrupts prostate cancer cells’ metabolism and releases cisplatin into the weakened cells,...
by Elana Gotkine For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), according to a study published online June 4 in The Lancet to coincide with the annual meeting of the American Society of Clinical Oncology, held from June 2 to 6 in Chicago. Neeraj Agarwal, M.D., from the...
by University of Connecticut Credit: Pixabay/CC0 Public Domain Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375,000 patients will die from it each year. Tumor resistance to current therapies plays an essential role in...
by Miriam Jones Bradley, RN No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated. Prostate cancer affects one in seven men. According to the American Cancer Society (ACS), it is the second most common type of cancer among...
by Stephanie Winn, UC Davis Credit: UC Davis Prostate cancer is the second leading cause of death in American men. Understanding the factors that influence patient outcomes is critical for improving treatment and survival rates. Research led by UC Davis Comprehensive Cancer Center reveals a link between bone metabolism biomarkers and survival in men with newly...
by University of California, San Francisco Credit: Pixabay/CC0 Public Domain Transgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk of prostate cancer has been unclear. Now a first of its kind study led by UC San Francisco has estimated the risk at about 14 cases per 10,000...
